Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Primary hypertension, anti-hypertensive medications and the risk of severe COVID-19 in UK Biobank
Authors
Keywords
-
Journal
PLoS One
Volume 17, Issue 11, Pages e0276781
Publisher
Public Library of Science (PLoS)
Online
2022-11-10
DOI
10.1371/journal.pone.0276781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis
- (2020) G David Batty et al. BMJ-British Medical Journal
- Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- (2020) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Hypertension and COVID-19
- (2020) Ernesto L Schiffrin et al. AMERICAN JOURNAL OF HYPERTENSION
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Use of distinct anti‐hypertensive drugs and risk for COVID‐19 among hypertensive people: a population‐based cohort study in Southern Catalonia, Spain
- (2020) Angel Vila‐Corcoles et al. Journal of Clinical Hypertension
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- COVID-19 and comorbidities: a systematic review and meta-analysis
- (2020) Morgan Spencer Gold et al. POSTGRADUATE MEDICINE
- COVID-19 and comorbidities: Deleterious impact on infected patients
- (2020) Hasan Ejaz et al. Journal of Infection and Public Health
- Dynamic linkage of COVID-19 test results between Public Health England’s Second Generation Surveillance System and UK Biobank
- (2020) Jacob Armstrong et al. Microbial Genomics
- A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
- (2020) Amanj Kurdi et al. Pharmacology Research & Perspectives
- Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
- (2016) Emmanuelle Vidal-Petiot et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started